4.7 Article

Involvement of MicroRNAs in the Cytotoxic Effects Exerted by Proinflammatory Cytokines on Pancreatic β-Cells

Journal

DIABETES
Volume 59, Issue 4, Pages 978-986

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/db09-0881

Keywords

-

Funding

  1. Swiss National Science Foundation [310000-122430, 310000-121999, 3100A0-113421, 31003A-127254]
  2. Juvenile Diabetes Research Foundation [1-2007-158]
  3. European Union [222980]
  4. IMI [Innovative Medicine Initiative]
  5. IMIDIA [Innovative Medicine Initiative Diabetes] [C2008-T7]
  6. Swiss National Science Foundation (SNF) [31003A_127254] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

OBJECTIVE-Pancreatic beta-cells exposed to proinflammatory cytokines display alterations in gene expression resulting in defective insulin secretion and apoptosis. MicroRNAs are small noncoding RNAs emerging as key regulators of gene expression. Here, we evaluated the contribution of microRNAs to cytokine-mediated beta-cell cytotoxicity. RESEARCH DESIGN AND METHODS-We used global microarray profiling and real-time PCR analysis to detect changes in microRNA expression in beta-cells exposed to cytokines and in islets of pre-diabetic NOD mice. We assessed the involvement of the microRNAs affected in cytokine-mediated beta-cell failure by modifying their expression in insulin-secreting MIN6 cells. RESULTS-We found that IL-1 beta and TNF-alpha induce the expression of niiR-21, miR-34a, and miR-146a both in MIN6 cells and human pancreatic islets. We further show an increase of these microRNAs in islets of NOD mice during development of prediabetic insulitis. Blocking miR-21, miR-34a, or miR-146a function using antisense molecules did not restore insulin-promoter activity but prevented the reduction in glucose-induced insulin secretion observed upon IL-1 beta exposure. Moreover, anti-miR-34a and anti-miR-146a treatment protected MIN6 cells from cytokine-triggered cell death. CONCLUSIONS-Our data identify miR-21, miR-34a, and miR-146a as novel players in beta-cell failure elicited in vitro and in vivo by proinflammatory cytokines, notably during the development of peri-insulitis that precedes overt diabetes in NOD mice. Diabetes 59:978-986, 2010

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available